FMB
IDXX icon

Field & Main Bank’s Idexx Laboratories IDXX Stock Holding History

Field & Main Bank’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Hold
20
– – ﹤0.01% 236
2026
Q1 		$11.2K Hold
20
– – ﹤0.01% 226
2025
Q4 		$13.5K Hold
20
– – ﹤0.01% 222
2025
Q3 		$12.8K Hold
20
– – ﹤0.01% 219
2025
Q2 		$10.7K Hold
20
– – ﹤0.01% 218
2025
Q1 		$8.4K Hold
20
– – ﹤0.01% 223
2024
Q4 		$8.27K Hold
20
– – ﹤0.01% 232
2024
Q3 		$10.1K Hold
20
– – ﹤0.01% 222
2024
Q2 		$9.74K Hold
20
– – ﹤0.01% 225
2024
Q1 		$10.8K Hold
20
– – ﹤0.01% 221
2023
Q4 		$11.1K Hold
20
– – ﹤0.01% 214
2023
Q3 		$8.74K Hold
20
– – ﹤0.01% 227
2023
Q2 		$10K Hold
20
– – 0.01% 225
2023
Q1 		$10K Hold
20
– – 0.01% 223
2022
Q4 		$8.16K Hold
20
– – 0.01% 237
2022
Q3 		$7K Hold
20
– – ﹤0.01% 237
2022
Q2 		$7K Hold
20
– – ﹤0.01% 260
2022
Q1 		$11K Hold
20
– – 0.01% 202
2021
Q4 		$13K Buy
+20
New +$12.6K 0.01% 203

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Field & Main Bank's IDXX Position: Q2 2026 in Review

Field & Main Bank held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 20 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

Field & Main Bank first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.5K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Field & Main Bank held 20 shares of Idexx Laboratories worth $10.5K as of Q2 2026.
  • Field & Main Bank left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Field & Main Bank's portfolio in Q2 2026, its #236 holding.
  • Field & Main Bank first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Field & Main Bank's Idexx Laboratories position peaked at $13.5K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Field & Main Bank's 13F filing for Q2 2026, filed 13 Aug 2026.